1-3 of 3
Guy Cavet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subtype specific differences in genetic alterations and drug response in breast cancer cell lines

Carol O'Brien, Heidi Savage, Jill Spoerke, Xiaolan Hu, Guy Cavet, Lukas Amler, Mark Lackner
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19_Supplement): B6.
Published: 15 August 2014
View articletitled, Subtype specific differences in genetic alterations and drug response in breast cancer cell lines
Journal Articles

In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models

Klaus P. Hoeflich, Carol O'Brien, Zachary Boyd, Guy Cavet, Steve Guerrero, Kenneth Jung, Tom Januario, Heidi Savage, Elizabeth Punnoose, Tom Truong, Wei Zhou, Leanne Berry, Lesley Murray, Lukas Amler, Marcia Belvin, Lori S. Friedman, Mark R. Lackner
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (14): 4649–4664.
https://doi.org/10.1158/1078-0432.CCR-09-0317
Published: 15 July 2009
View articletitled, In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models
Open the PDF for In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models in another window
Includes: Supplementary data
Journal Articles

Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients

Robert L. Yauch, Thomas Januario, David A. Eberhard, Guy Cavet, Wenjing Zhu, Ling Fu, Thinh Q. Pham, Robert Soriano, Jeremy Stinson, Somasekar Seshagiri, Zora Modrusan, Chin-Yu Lin, Vincent O'Neill, Lukas C. Amler
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8686–8698.
https://doi.org/10.1158/1078-0432.CCR-05-1492
Published: 16 December 2005
View articletitled, Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients
Open the PDF for Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients in another window